Answer
Reported gastrointestinal side effects of eribulin mesylate include appetite loss, nausea, vomiting, diarrhoea, constipation, abdominal pain, stomatitis, dry mouth, dyspepsia, gastrooesophageal reflux disease, abdominal distension, mouth ulceration and pancreatitis.
Sources for this answer
- Eribulin Eisai 0.44 mg/ml solution for injectionEisai Ltd · emc · SmPC §4.8 Undesirable effects · Version 26Document updated
Sources checked